The present findings raise the question of whether ABCB1 and ABCG2 polymorphisms might explain genetic susceptibility to cannabis-induced psychosis or the adverse psychoactive effects of this drug (e.g. addiction, anxiety and cognitive impairment) by altering the brain disposition of THC. The gene discussed is ABCB1; the disease is Cognitive impairment.